Capped LIRNs® Linked to the Russell 2000® Index | ![]() This graph reflects the hypothetical return on the notes, based on the mid-point of the range(s) set forth in the table to the left. This graph has been prepared for purposes of illustration only. | |
Issuer | BofA Finance LLC (BofA Finance) | |
Guarantor | Bank of America Corporation (BAC) | |
Principal Amount | $10.00 per unit | |
Term | Approximately two years | |
Market Measure | The Russell 2000® Index (Bloomberg symbol: RTY) | |
Payout Profile at Maturity | ● 2-to-1 upside exposure to increases in the Market Measure, subject to the Capped Value ● 1-to-1 downside exposure to decreases in the Market Measure beyond a 10% decline, with up to 90% of your principal at risk | |
Capped Value | [$11.40 to $11.80] per unit, a [14% to 18%] return over the principal amount to be determined on the pricing date. | |
Threshold Value | 90% of the Starting Value of the Market Measure | |
Interest Payments | None | |
Preliminary Offering Documents | ||
Exchange Listing | No |
● | Depending on the performance of the Market Measure as measured shortly before the maturity date, your investment may result in a loss; there is no guaranteed return of principal. |
● | Payments on the notes are subject to the credit risk of BofA Finance and the credit risk of BAC, and actual or perceived changes in the creditworthiness of BofA Finance or BAC are expected to affect the value of the notes. If BofA Finance and BAC become insolvent or are unable to pay their respective obligations, you may lose your entire investment. |
● | Your investment return is limited to the return represented by the Capped Value and may be less than a comparable investment directly in the stocks included in the Market Measure. |
● | The initial estimated value of the notes on the pricing date will be less than their public offering price. |
● | If you attempt to sell the notes prior to maturity, their market value may be lower than both the public offering price and the initial estimated value of the notes on the pricing date. |
● | You will have no rights of a holder of the securities represented by the Market Measure, and you will not be entitled to receive securities or dividends or other distributions by the issuers of those securities. |
● | The notes are subject to risks associated with small-size capitalization companies. |
TQ$12(/M[E'N/MH*77Y.G35BU6>O7*3=NW3,JL
MLJ<"$3(4-F,8P]@ 1$1]E?K4=\K"SCW7@Z\'07;<,,2%M^4D#(13LB";\4
MVIS@BYV0QCI")-"4HEV!A 1H*B-QV\6!+=1IZ."%.V*]+)"Z)X4S Q)V
MS(0I7!FL'.)*)O6G)PH8_4*J 3UWRQX^+!W#Q$1(G:RIG\:(>>4#-=\6:G4 Q" HJ3:HD'D*
M9BD[>O7RJ1[K*"*B<_&*-K/=-W\7(6],Q106DAZP$(N8_5'B@8A#B5,Q , V] &UO\ 5M5"Q+C7
MOHI36VG$/#S!3%.8!8@B85P$">N/[/GV+ZW\.] H&M]Z"=^5[FS(^(+UQ:%E2O0B9!:5?W$T\(BMXM@R*V65+R.0QR:1%P.
MR"4>_P#@&OS\N/.E^XHL>&/B:=382SLYY-T\*W0<@2-3,DB/JJD.31UGC8 -
MK?8=#[:]#RAH1A H"4Q0,/!T5 1$-A^Q$0V'>@ZAMN[K>N\LDI;LAXLD
M1).(AX8$5" F[0$"JI@)RASXF'0F+LNP$-[ =>Q6&PA9KRPL5V];LKWE0:^,
ME3"'<[]P85W(C_']LHI_\-5N:!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E
M*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*!2E*"58;^D7.W_,!G_VK TIAOZ1
M<[?\P&?_ &K TH'DT_1U+_\ ,"^_^ZI2JK4J\FGZ.I?_ )@7W_W5*55:!2E<
ML6CY8&6;GL9OEG^RO(FL4Y%EUY6/NIJ[<)H(J'364*T%,BI^)DS[#U>Q1'>N
M]!U/2LU WHWNL]OR=L-TI"W)^(6E4Y4KHI1((&;]%/H#ZYNH594PF[ F*/$P
M;.6M+0*4KQ[IN>/M&,1E9-)PHBO)1\64$"@8P*O':+5(1V(!Q!1<@F'>P* B
M ".@$/8I6?R%=?R#L&Y;Y\!X[Y.P[V6\+U>EU_#HG5Z?/1N/+AKEH=;WH?93
M'MU_+RP;:OGP'@?E%#LI;PO5ZO0\0B17I\]%Y<>>N6@WK>@]E!H*4I0*4KQ[
MIN>/M&,1E9-)PHBO)1\64$"@8P*O':+5(1V(!Q!1<@F'>P* B ".@$/8I2E
MI2E I7CP=SQ\_)W#%,DG!%K:DB1;L5"@!3JF:-W0"30B(EZ;I,-B #R P:T
M"/ZMY&25N1]$*Q)4V#9BT 1FR [$!$.'80 3;\^9L*T[@NRW+YEXKQ$W:?C/,[KKJD\-XI($E_4
M*8"'Y$ ]<#:]H:'O0<%9QO!WFW!MSWS)"8REB69!PCLBG?ISKR6:B_U_ Q2
MLT2C]>E:N,I9F"\[7CD6]LD3 S7M !, \Z8)Q_;SO)]OS5G>3
M+/XQ\Q*N)2XG\PB9--P\,S7:D:L>:AQ.CMTJ?9 (329-AO5!N_*[_P#P5_YP
M6Y_^_7]^4F*=Q9!PM9$&J52X4;X:7$HFD.U$(MHDJ+E0^NY"&YD* CH##V#8
M]JIN4,1X]S- -[7R5;_GB,:O"/TD/%KM^*Y2'(4_)$Y##ZJIPT(Z[^S8!KSL
M6X!Q!A8[Q;&=DMH9>0*!'"_76<+'( [ G46.E"]_=RR)_/6]\4H*)2IWZ4+W]W+(G\];WQ2GI0O?W
E
M"]_=RR)_/6]\4H*)2IWZ4+W]W+(G\];WQ2GI0O?W
M/Y2Z:I7-?]J?,_N39-_FF/^I3^U/F?W)LF_P TQ_U*I_RMGY;>2/
M74_(ETI2N:_[4^9_
_NY9$_GK>^*4]*%[^[ED3^>M[XI042E3OTH7O[
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MTQEHQY)*5:RZZ*BP( 6+AW
W#,EG+W\ \0BY(LC;3=%%9 [$!;=(1<[5$BZNSK:'@ $ P:#D'*@\Q&-4RV
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M,A(SCP)Q\**9S)JIC_O&!4B@"?OR'9MCO=D(
MBFT8-2-T2"/M$"$ "AO_ (4'.=PX\98C83,;94G<-PO;=A7=\/W,Z_,_UK;=86D2NH)BL$OF(3OP4
M0*;Q(C? (")]AZVT0!/O^[V]E>9Y2]KSTXME..LUN
DV[L8V9?L3]!JN@4&Y7*O@
MSB"P (F4:@@H;7L,<0$"B'$)="9QR$CY;-T8IFIDJUCD39QT$'J@0%#
M5'6):<1=\O?D=#)H3T^BW;R3PIS\G!$ $J0&*(\0$H#K8 B B.
M@T'*/E(0$A.^4O/.(0NYBW\/(W'%" >L#QA/%>MRX\OJWKM7@LL"XFCK6MFRV5HD1AK.F4K@A6I
M7CC_ &5^FHHH1;EU.2FC*J#Q.)BCO0AH XMNU?)-T2]]Y<+B1X[GK